APA (7th ed.) Citation

Yates, T. A., Barnes, S., Dedicoat, M., Kon, O. M., Kunst, H., Lipman, M., . . . Squireg, S. B. (2024). Drug-resistant tuberculosis treatments, the case for a phase III platform trial. Bulletin of the World Health Organization, 102(9), 657. https://doi.org/10.2471/BLT.23.290948

Chicago Style (17th ed.) Citation

Yates, Tom A., et al. "Drug-resistant Tuberculosis Treatments, the Case for a Phase III Platform Trial." Bulletin of the World Health Organization 102, no. 9 (2024): 657. https://doi.org/10.2471/BLT.23.290948.

MLA (9th ed.) Citation

Yates, Tom A., et al. "Drug-resistant Tuberculosis Treatments, the Case for a Phase III Platform Trial." Bulletin of the World Health Organization, vol. 102, no. 9, 2024, p. 657, https://doi.org/10.2471/BLT.23.290948.